| | Title | Authors / Editors | Date |
|
unige:154003 |
Phase II trial of IL-12 plasmid transfection and PD-1 blockade in immunologically quiescent melanoma |
Algazi, Alain P; Twitty, Christopher G; Tsai, Katy K; Le, Mai; ... Daud, Adil I |
2020 |
|
unige:154044 |
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy |
Rodell, Christopher B; Arlauckas, Sean P; Cuccarese, Michael F; Garris, Christopher S; ... Weissleder, Ralph |
2018 |
|
unige:154047 |
Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-γ and IL-12 |
Garris, Christopher S; Arlauckas, Sean P; Kohler, Rainer H; Trefny, Marcel P; ... Pittet, Mikaël |
2018 |
|
unige:154048 |
Recording the wild lives of immune cells |
Pittet, Mikaël; Garris, Christopher S; Arlauckas, Sean P; Weissleder, Ralph |
2018 |
|
unige:154053 |
In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy |
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H; Kitaoka, Maya; ... Pittet, Mikaël |
2017 |
Arlauckas, Sean P
add all
remove all
